Below you will find a list of my publication(s).

As you can see it aren’t many at the moment, so please remember I’m still in the early phase of my PhD 😉

van Miert JHA; Veeger NJGM; Meijer K, 2019. An easy-to-use tool to flag patients at risk of poor INR control: A streak of subtherapeutic INRs.  Thromb Res 181:46-51

van Miert JHA; Kooistra HAM; Veeger NJGM; Westerterp A; Piersma-Wichers M; Meijer K, 2019. Choosing between continuing vitamin K antagonists (VKA) or switching to a direct oral anticoagulant in currently well-controlled patients on VKA for atrial fibrillation: a randomised controlled trial (GAInN).  Br J Haematol 186(3):e21-e23

van Miert JHA; Meijer K, 2018. Re: Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation.  Pharmacoepidemiol Drug Saf 27(2):243

van Miert JHA; Bos S; Veeger NJGM; Meijer K, 2018. Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis.  PLoS One 13(3):e0194208

van Miert JH; Hop H; Borjas-Howard JF; Meijer K, 2016. A milder clinical course for severe hemophilia B: a true or biased effect?  Haematologica 101(6):e266

Publication list retrieved from NCBI using ImpactPubs